- Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol. Brodde, O.E., Daul, A., Michel-Reher, M., Boomsma, F., Man in 't Veld, A.J., Schlieper, P., Michel, M.C. Circulation (1990)